FeetrAI Performance
We analyze the accuracy of our AI-generated stock price predictions over a 10-day period. The data illustrates how closely stock prices align with our targets, broken down into different accuracy ranges: exact matches, within 1%, 5%, and 10% of the target price. Each dot on the target represents an instance of a stock prediction, with closer hits indicating higher precision.
We also track how quickly these targets are met, providing insights into the timeliness of our predictions. The first price target is typically achieved within 23 hours, while the second price target takes an average of 42 hours to hit.
This performance evaluation highlights both the precision and speed of our predictions, ensuring you stay informed with actionable insights.
We’ve analyzed 5493 stocks analyzed so far—here’s how FeetrAI performed!
First Price Target
Exact:
85.29%
Within 1%:
91.52%
Within 5%:
96.32%
Within 10%:
97.85%
Average time until target:
23 hours
Second Price Target
Exact:
69.51%
Within 1%:
77.21%
Within 5%:
89.53%
Within 10%:
95.56%
Average time until target:
42 hours
Here's FeetrAI in action 🔥
$BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals (BDRX) is experiencing a significant surge in trading volume, currently at 151,842, far exceeding its 65-day average of 22,081, indicating heightened interest and potential volatility. The stock's RSI values are deeply oversold, suggesting a possible rebound, while the MACD histogram turning positive hints at bullish momentum. Despite broader market uncertainties, BDRX's recent price action shows a strong upward movement from $7.80 to $14.95, with a current price of $11.59, reflecting a volatile but potentially lucrative trading opportunity. Given the technical indicators and today's trading dynamics, consider entering a long position around $11.50. Set a first price target at $14.00 with moderate confidence due to recent highs, and a second target at $16.00 with lower confidence, considering potential resistance. Implement a stop loss at $10.50 to manage downside risk, acknowledging the stock's inherent volatility. Overall, the analysis suggests a cautiously optimistic outlook for BDRX in today's session, driven by technical recovery signals and increased trading activity.
Entry
$11.50
PT1
$14.00
PT2
$16.00
Stop Loss
$10.50
Realised profit: 39.13%
Generated: October 16, 2024 at 07:27 AM
$ONMD OneMedNet Corp
OneMedNet Corp (ONMD) has shown significant volatility with a sharp increase in volume, currently at 5.4M compared to its 65-day average of 585K, indicating heightened interest. The stock's RSI values are extremely high (6-day RSI at 95.2), suggesting it is overbought, while the MACD histogram is positive, indicating bullish momentum. Recent price action shows strong buying pressure, with the stock closing at $1.40 after hitting a high of $1.65. Given the current market sentiment and technical indicators, I recommend a long position with an entry around $1.35. Set the first price target at $1.60 and the second at $1.75, with a stop loss at $1.20 to manage risk. Confidence in reaching the first target is high due to the strong momentum and volume, while the second target has moderate confidence given potential profit-taking. Monitor for any news that could impact the stock's movement throughout the day.
Entry
$1.35
PT1
$1.60
PT2
$1.75
Stop Loss
$1.20
Realised profit: 29.63%
Generated: May 23, 2024 at 09:32 AM
$AEMD Aethlon Medical, Inc.
Aethlon Medical Inc. (AEMD) has shown significant volatility recently, with a notable spike in volume and price fluctuations. The stock's current price of $0.8009 is above its 10-day SMA ($0.4247) and 20-day EMA ($0.6178), indicating potential bullish momentum. However, the RSI values (6-day: 38.8, 14-day: 23.6) suggest it is still in oversold territory, which could lead to a rebound. The MACD histogram turning positive further supports a possible upward movement. Given the high trading volume and recent price action, an entry at $0.82 is recommended. Target prices are set at $0.95 (first target) and $1.10 (second target), with a stop loss at $0.75 to manage risk. Confidence in reaching the first target is moderate (70%) due to the technical indicators, while the second target has lower confidence (50%) given broader market uncertainties.
Entry
$0.82
PT1
$0.95
PT2
$1.10
Stop Loss
$0.75
Realised profit: 34.15%
Generated: June 06, 2024 at 05:09 AM
$AKAN Akanda Corp.
Akanda Corp. (AKAN) is experiencing a significant surge in trading volume, currently at 744,443 compared to its 65-day average of 201,220, indicating heightened interest and potential volatility. The stock's RSI values are elevated, with the 6-day RSI at 82.28, suggesting overbought conditions, yet the MACD histogram is positive, hinting at bullish momentum. Recent price action shows a strong upward movement from $1.13 to a high of $1.88, followed by consolidation around $1.33, which could signal a continuation pattern if the broader market sentiment remains supportive. Given the current technical setup, consider entering a long position around $1.30, with a first price target of $1.50 and a second target of $1.70, while setting a stop loss at $1.20 to manage downside risk. Confidence in reaching the first target is moderate due to the strong volume and momentum indicators, while the second target carries lower confidence given potential profit-taking and overbought signals. Broader market trends, particularly in tech and consumer discretionary sectors, may influence AKAN's trajectory, so monitor SPY and QQQ for cues. Overall, the stock presents an intriguing short-term opportunity, but caution is advised due to potential volatility and external market factors.
Entry
$1.30
PT1
$1.50
PT2
$1.70
Stop Loss
$1.20
Realised profit: 30.77%
Generated: October 18, 2024 at 09:51 AM
$AMIX Autonomix Medical, Inc.
Autonomix Medical, Inc. (AMIX) is experiencing significant volatility with a current price of $13.37, following a sharp rise and subsequent pullback from highs around $21.49. The stock's volume today is substantially above its 65-day average, indicating heightened interest and potential for further movement. Technical indicators show a bullish momentum with the RSI nearing overbought levels, suggesting caution but also potential for continued upward movement if buying pressure persists. The MACD histogram is positive, supporting a short-term bullish outlook. Given the broader market's cautious optimism, AMIX could benefit from sector strength in healthcare, though it remains sensitive to broader economic uncertainties. For today's session, consider entering around $13.50, targeting $15.00 as the first target and $17.00 as the second, with a stop loss at $12.50. Confidence in reaching the first target is moderate due to strong volume and momentum, while the second target carries lower confidence given potential resistance and market volatility.
Entry
$13.50
PT1
$15.00
PT2
$17.00
Stop Loss
$12.50
Realised profit: 25.93%
Generated: October 28, 2024 at 12:05 PM